De-epimerizing DyKAT of β-Lactones Generated by Isothiourea-Catalysed Enantioselective [2+2] Cycloaddition

29 January 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Moderate diastereoselectivity (typically 70:30 dr) is observed in the isothiourea-catalysed [2+2]-cycloaddition of C(1)-ammonium enolates with pyrazol-4,5-diones to generate spirocyclic β lactones, but subsequent ring-opening with morpholine generatesβ hydroxyamide products with enhanced stereoselectivity (up to >95:5 dr). Stereoconvergence is observed in the ring-opening of diastereoisomeric β-lactones, leading to a single product (>95:5 dr, >99:1 er). Mechanistic studies and DFT analysis indicate a substrate controlled Dynamic Kinetic Asymmetric Transformation (DyKAT) involving epimerisation at C(3) of the β-lactone under the reaction conditions, coupled with a hydrogen bond-assisted nucleophilic addition to the Si face of the β-lactone and stereodetermining ring-opening. The scope and limitations of a one-pot protocol consisting of isothiourea-catalysed enantio-determining [2+2] cycloaddition followed by diastereo-determining ring-opening is subsequently developed. Variation within the anhydride ammonium enolate precursor, as well as N(1)- and C(3)- within the pyrazol-4,5-dione scaffold is demonstrated, giving a range of functionalised β hydroxyamides with high diastereo- and enantiocontrol (>20 examples, up to >95:5 dr and >99:1 er) via this DyKAT.

Keywords

DyKAT
epimerization
ring-opening
b-lactone
DFT analysis

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Supporting information for publication
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.